Page 13 - Small Cap U.S. Pharmaceuticals & Biotech Stocks by Market Cap

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
UNCY Unicycive Therapeutics	US$0.68	33.1%	32.7%	US$61.3m	US$5.50	PB2.5x	E58.8%	n/a
SPRO Spero Therapeutics	US$1.13	-5.8%	-3.4%	US$61.6m	US$5.00	PE17.5x	E40.4%	n/a
CASI CASI Pharmaceuticals	US$3.97	-24.5%	-22.6%	US$62.3m	US$6.00	PS2.7x	E9.0%	n/a
LSB LakeShore Biopharma	US$2.98	13.9%	-51.9%	US$62.4m	n/a	PB0.7x	n/a	n/a
CELU Celularity	US$2.01	-31.6%	-4.5%	US$62.7m	n/a	PS1x	n/a	n/a
IMRX Immuneering	US$2.13	4.4%	-67.6%	US$63.7m	US$11.21	PB1.1x	E-11.3%	n/a
CLRB Cellectar Biosciences	US$1.53	-1.9%	-31.7%	US$64.4m	US$13.33	PB40.8x	E72.4%	n/a
ZYNE Zynerba Pharmaceuticals	US$1.30	4.0%	96.1%	US$65.6m	US$1.26	PB2.3x	E67.2%	n/a
CRVO CervoMed	US$9.16	-5.0%	-7.8%	US$65.9m	US$50.29	PS7.5x	E-42.9%	n/a
MURA Mural Oncology	US$4.04	19.9%	7.7%	US$67.1m	US$16.33	PB0.4x	E14.9%	n/a
CUE Cue Biopharma	US$1.22	11.9%	-45.3%	US$69.1m	US$3.60	PS8.1x	E-2.1%	n/a
XGN Exagen	US$3.84	-8.6%	152.6%	US$69.5m	US$6.25	PS1.2x	E24.7%	n/a
IVVD Invivyd	US$0.67	-12.2%	-55.6%	US$70.6m	US$6.51	PS7x	E72.2%	n/a
ATRA Atara Biotherapeutics	US$12.18	14.0%	-29.6%	US$70.6m	US$14.75	PE-0.5x	E36.7%	n/a
CTOR Citius Oncology	US$0.94	-5.0%	-91.4%	US$71.0m	US$3.00	PB3.9x	E58.0%	n/a
LABP Landos Biopharma	US$22.93	2.0%	693.4%	US$71.7m	US$20.42	PB3.1x	E-37.1%	n/a
BLUE bluebird bio	US$0.38	24.7%	-90.2%	US$71.9m	US$2.36	PS1.4x	E49.0%	n/a
VTGN Vistagen Therapeutics	US$2.69	3.1%	-27.1%	US$72.4m	US$13.00	PS85.5x	E9.2%	n/a
BYSI BeyondSpring	US$1.89	10.5%	114.8%	US$74.6m	n/a	PS40.6x	n/a	n/a
MGX Metagenomi	US$2.02	22.4%	n/a	US$75.2m	US$17.00	PS1.4x	E-23.2%	n/a
BCAB BioAtla	US$1.64	10.8%	-3.5%	US$75.9m	US$10.67	PS7.2x	E-6.5%	n/a
IMAB I-Mab	US$0.95	-3.0%	-38.3%	US$77.2m	US$6.75	PS23.4x	E1.8%	n/a
AVTE Aerovate Therapeutics	US$2.64	-0.8%	-83.5%	US$77.4m	US$2.33	PB0.9x	E43.9%	n/a
OVID Ovid Therapeutics	US$1.11	6.7%	-63.6%	US$77.4m	US$3.26	PS124.8x	E-20.6%	n/a